PIC Therapeutics Funding: $40M Raised, Series A (2022)
PIC Therapeutics is based in Greater Boston. It has raised $40M in total funding. Latest round: Series A.
PIC Therapeutics funding overview
PIC Therapeutics is based in Greater Boston. PIC Therapeutics has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in October 2022. The round record for PIC Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include OrbiMed, Lumira Ventures, Harrington Discovery Institute, Advent Life Sciences. 4 distinct backers are named across the disclosed rounds.
PIC Therapeutics at a glance
Total raised
$40M
Latest round
Series A
Latest round date
October 2022
Headquarters
Greater Boston
Notable investors
OrbiMed, Lumira Ventures, Harrington Discovery Institute, Advent Life Sciences
Frequently asked about PIC Therapeutics funding
How much has PIC Therapeutics raised?
PIC Therapeutics has raised $40M in total disclosed funding across the rounds on record.
Who has invested in PIC Therapeutics?
OrbiMed, Lumira Ventures, Harrington Discovery Institute, Advent Life Sciences are named among the investors backing PIC Therapeutics.
What was the latest PIC Therapeutics funding round?
The most recent disclosed round is a Series A, announced in October 2022.
Where is PIC Therapeutics based?
PIC Therapeutics is based in Greater Boston.
When did PIC Therapeutics last raise?
The last disclosed PIC Therapeutics round closed in October 2022 at Series A.
PIC Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Greater Boston below to benchmark round size and investor mix.
